Growth-promoting composition and its use
US5374620A · kind A · utility
88Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 1993 |
| Grant date | Dec 20, 1994 |
| Priority date | — |
| Expiry date | Jun 4, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combined formulation for IGF-I and growth hormone (GH) is useful for enhancing growth of a mammal. This formulation, which may be administered by infusion or injection to enhance growth, comprises IGF-I and GH, each in amounts of 0.1 to 100 mg/ml, in a pharmaceutically acceptable carrier at a pH of about 5-6 containing a surfactant, wherein the amounts of IGF-I and GH in the composition are effective to promote growth of a mammal more than an equivalent dose of IGF-I or GH alone, and wherein the weight ratio of IGF-I to GH in the composition ranges from 0.002:1 to 240:1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.